Medincell SA operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medincell SA with three other
pharmaceutical manufacturers in Europe:
Moberg Pharma AB (publ)
of SWEDEN
(2020
sales of 50.49 million Swedish Kronor [US$6.10 million]
),
Oncimmune Holdings PLC
of UNITED KINGDOM
(£509,000.00 [US$696,306.91 ]
of which 100%
was Distribution of testing products), and
Provexis PLC
which is
also
based in UNITED KINGDOM
(£347,937.00 [US$475,974.34 ]
).
Sales Analysis.